Northern Trust Corp Grows Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Northern Trust Corp lifted its stake in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 3.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 285,872 shares of the company's stock after purchasing an additional 9,122 shares during the period. Northern Trust Corp owned approximately 1.58% of Addus HomeCare worth $35,834,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of ADUS. Susquehanna Fundamental Investments LLC purchased a new position in Addus HomeCare during the fourth quarter worth about $1,716,000. Nebula Research & Development LLC increased its holdings in shares of Addus HomeCare by 90.5% in the 4th quarter. Nebula Research & Development LLC now owns 14,225 shares of the company's stock valued at $1,783,000 after acquiring an additional 6,757 shares during the last quarter. Oberweis Asset Management Inc. raised its position in shares of Addus HomeCare by 23.5% during the 4th quarter. Oberweis Asset Management Inc. now owns 59,900 shares of the company's stock worth $7,508,000 after purchasing an additional 11,400 shares during the period. Voya Investment Management LLC lifted its position in Addus HomeCare by 1.7% in the 4th quarter. Voya Investment Management LLC now owns 224,559 shares of the company's stock valued at $28,148,000 after purchasing an additional 3,855 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its holdings in shares of Addus HomeCare by 0.5% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 226,636 shares of the company's stock valued at $28,410,000 after purchasing an additional 1,087 shares during the period. Institutional investors and hedge funds own 95.35% of the company's stock.

Addus HomeCare Stock Performance

Shares of ADUS traded down $0.81 during mid-day trading on Tuesday, reaching $109.74. The company had a trading volume of 117,672 shares, compared to its average volume of 164,961. The company's 50 day simple moving average is $99.15 and its 200 day simple moving average is $114.14. The company has a market capitalization of $2.02 billion, a price-to-earnings ratio of 25.11, a P/E/G ratio of 1.41 and a beta of 0.85. Addus HomeCare Co. has a 1-year low of $88.96 and a 1-year high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping analysts' consensus estimates of $1.33 by $0.09. The company had revenue of $337.71 million for the quarter, compared to analyst estimates of $341.66 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm's quarterly revenue was up 20.3% on a year-over-year basis. During the same period in the previous year, the firm earned $1.21 earnings per share. As a group, equities analysts forecast that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts have recently commented on ADUS shares. JMP Securities reaffirmed a "market outperform" rating and issued a $150.00 target price on shares of Addus HomeCare in a research report on Tuesday, April 22nd. Macquarie raised their price objective on Addus HomeCare from $129.00 to $133.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. StockNews.com downgraded Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Oppenheimer boosted their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Finally, Stephens restated an "overweight" rating and set a $142.00 price target on shares of Addus HomeCare in a research note on Wednesday, March 12th. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus target price of $142.57.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.